C07C 309/30
Of six-membered aromatic rings substituted by alkyl groups
Official title: of six-membered aromatic rings substituted by alkyl groups
C07C309/30 (Of six-membered aromatic rings substituted by alkyl groups) appears on 272 US grants and 387 published applications in this corpus.
Search patents in C07C- Granted patents
- 272
- Published applications
- 387
- Assignees
- 237
- Inventors
- 1,024
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 2 | 0 |
| 1986 | 2 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 3 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 1 |
| 2002 | 0 | 1 |
| 2003 | 3 | 3 |
| 2004 | 1 | 5 |
| 2005 | 3 | 5 |
| 2006 | 1 | 3 |
| 2007 | 2 | 10 |
| 2008 | 5 | 4 |
| 2009 | 5 | 7 |
| 2010 | 4 | 9 |
| 2011 | 3 | 4 |
| 2012 | 6 | 7 |
| 2013 | 9 | 18 |
| 2014 | 7 | 18 |
| 2015 | 22 | 26 |
| 2016 | 28 | 32 |
| 2017 | 16 | 26 |
| 2018 | 22 | 24 |
| 2019 | 22 | 21 |
| 2020 | 11 | 18 |
| 2021 | 12 | 21 |
| 2022 | 19 | 31 |
| 2023 | 9 | 21 |
| 2024 | 13 | 26 |
| 2025 | 15 | 27 |
| 2026 | 7 | 19 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Magnesium sulfonate detergent having improved compatibility with friction modifiers6 Oct 2026US 12,753,362 B2Afton Chemical Corporation
- Pharmaceutically acceptable salts of sepiapterin26 May 2026US 12,637,465 B2PTC Therapeutics MP, Inc.
- Pyrrolidine amide derivative salt and use thereof19 May 2026US 12,630,507 B2Sunshine Lake Pharma Co., Ltd.
- Salt and crystal form of pyrimidine compound, and preparation methods therefor19 May 2026US 12,630,557 B2Ellipses Pharma Limited
- Salt form and crystal form of A2A receptor antagonist and preparation method therefor24 Mar 2026US 12,583,869 B2Cstone Pharmaceutical (Suzhou) Co., Ltd.
- Salt and crystal form of anti-tumor heterocyclic compound8 Oct 2026US 2026/0308143 A1Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd.
- Glycopyrrolate salts24 Sep 2026US 2026/0284007 A1Journey Medical Corporation
- Ammonium styrenesulfonate composition excellent in storage stability, and method for producing same17 Sep 2026US 2026/0274790 A1Sagami Chemical Research Institute
- Salt and solid forms of a cdk inhibitor17 Sep 2026US 2026/0274843 A1Genentech, Inc.
- Pharmaceutically acceptable salt and crystal form of 1,4-dihydro-1,6-naphthyridine amide compound and preparation method therefor10 Sep 2026US 2026/0265249 A1Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Most cited
By later US patents
- 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid addition salt and salt crystals108US 8,648,077 B2Intra-Cellular Therapies, Inc. · 2014
- 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid addition salt and salt crystals86US 9,199,995 B2Intra-Cellular Therapies, Inc. · 2015
- 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de] quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid salt crystal forms78US 9,586,960 B2Intra-Cellular Therapies, Inc. · 2017
- Functionalized ionic liquids, and methods of use thereof64US 7,208,605 B2University of South Alabama · 2007
- Detergent alkylation process using a fluorided silica-alumina58US 5,196,574 AUop LLC · 1993